Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 332

The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.

The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space

Open access
Klughammer, Johanna, Kiesel, Barbara, Roetzer, Thomas, Fortelny, Nikolaus, Nemc, Amelie, Nenning, Karl-Heinz, Furtner, Julia, Sheffield, Nathan C., Datlinger, Paul, Peter, Nadine, Nowosielski, Martha, Augustin, Marco, Mischkulnig, Mario, Ströbel, Thomas, Alpar, Donat, Ergüner, Bekir, Senekowitsch, Martin, Moser, Patrizia, Freyschlag, Christian F., Kerschbaumer, Johannes, Thomé, Claudius, Grams, Astrid E., Stockhammer, Günther, Kitzwoegerer, Melitta, Oberndorfer, Stefan, Marhold, Franz, Weis, Serge, Trenkler, Johannes, Buchroithner, Johanna, Pichler, Josef, Haybaeck, Johannes, Krassnig, Stefanie, Mahdy Ali, Kariem, von Campe, Gord, Payer, Franz, Sherif, Camillo, Preiser, Julius, Hauser, Thomas, Winkler, Peter A., Kleindienst, Waltraud, Würtz, Franz, Brandner-Kokalj, Tanisa, Stultschnig, Martin, Schweiger, Stefan, Dieckmann, Karin, Preusser, Matthias, Langs, Georg, Baumann, Bernhard, Knosp, Engelbert, Widhalm, Georg, Marosi, Christine, Hainfellner, Johannes A., Woehrer, Adelheid, Bock, Christoph·2018·Nature Medicine

Abstract

Glioblastoma is characterized by widespread genetic and transcriptional heterogeneity, yet little is known about the role of the epigenome in glioblastoma disease progression. Here, we present genome-scale maps of DNA methylation in matched primary and recurring glioblastoma tumors, using data from a highly annotated clinical cohort that was selected through a national patient registry. We demonstrate the feasibility of DNA methylation mapping in a large set of routinely collected FFPE samples, and we validate bisulfite sequencing as a multipurpose assay that allowed us to infer a range of different genetic, epigenetic, and transcriptional characteristics of the profiled tumor samples. On the basis of these data, we identified subtle differences between primary and recurring tumors, links between DNA methylation and the tumor microenvironment, and an association of epigenetic tumor heterogeneity with patient survival. In summary, this study establishes an open resource for dissecting DNA methylation heterogeneity in a genetically diverse and heterogeneous cancer, and it demonstrates the feasibility of integrating epigenomics, radiology, and digital pathology for a national cohort, thereby leveraging existing samples and data collected as part of routine clinical practice. In-depth methylation analysis of formalin-fixed paraffin-embedded glioblastoma samples demonstrates heterogeneity between primary and recurring tumors and enables prediction of composition of the tumor microenvironment and insights into progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-018-0156-x

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 106 references

Cited by

See all 332

Metadata

Authors
Klughammer, J., Kiesel, B., Roetzer, T., Fortelny, N., Nemc, A., Nenning, K.-H., Furtner, J., Sheffield, N. C., Datlinger, P., Peter, N., Nowosielski, M., Augustin, M., Mischkulnig, M., Ströbel, T., Alpar, D., Ergüner, B., Senekowitsch, M., Moser, P., Freyschlag, C. F., Kerschbaumer, J., Thomé, C., Grams, A. E., Stockhammer, G., Kitzwoegerer, M., Oberndorfer, S., Marhold, F., Weis, S., Trenkler, J., Buchroithner, J., Pichler, J., Haybaeck, J., Krassnig, S., Mahdy Ali, K., von Campe, G., Payer, F., Sherif, C., Preiser, J., Hauser, T., Winkler, P. A., Kleindienst, W., Würtz, F., Brandner-Kokalj, T., Stultschnig, M., Schweiger, S., Dieckmann, K., Preusser, M., Langs, G., Baumann, B., Knosp, E., Widhalm, G., Marosi, C., Hainfellner, J. A., Woehrer, A., & Bock, C.
Venue
Nature Medicine
Published
2018-08-27
Volume
24
Issue
10
Pages
1611-1624
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2949476985
Cited by
332
References
106
FWCI
17.17
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space. https://app.cochat.ai/papers/10.1038/s41591-018-0156-x
The paper
Klughammer, J., Kiesel, B., Roetzer, T., Fortelny, N., Nemc, A., Nenning, K.-H., Furtner, J., Sheffield, N. C., Datlinger, P., Peter, N., Nowosielski, M., Augustin, M., Mischkulnig, M., Ströbel, T., Alpar, D., Ergüner, B., Senekowitsch, M., Moser, P., Freyschlag, C. F., . . . Bock, C. (2018). The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space. Nature Medicine. https://doi.org/10.1038/s41591-018-0156-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.